Notice: This company has been marked as potentially delisted and may not be actively trading. Atrion (ATRI) Dividend Yield, Date & History Add Compare Share Share Dividend Stock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Dividend SummaryDividend Yield1.91%Annual Dividend$8.80Dividend Increase Track Record 21 YearsAnnualized 3-Year Dividend Growth 9.65%Dividend Payout Ratio 82.71% Recent Dividend Payment Jun. 28 Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Email Address Skip Charts & View Dividend HistoryATRI Dividend PaymentsOpen Atrion in Dividend Calculator ATRI Dividend Yield Over Time Open Atrion in Dividend Yield Calculator Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Atrion vs. The CompetitionTypeAtrionMedical CompaniesNASDAQ CompaniesAnnual Dividend$8.80$6.25$1.27Dividend Yield1.91%513.66%402.97%Annualized 3-Year Dividend Growth9.65%16.19%14.35%Track Record21 years23 years17 yearsAtrion Dividend Payout RatioTypePayout RatioBased on Trailing 12 Months of Earnings82.71%Based on Cashflow44.72% Atrion Dividend History by QuarterAnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/21/2024Quarterly$2.201.86%6/14/20246/14/20246/28/20242/27/2024Quarterly$2.202.42%3/14/20243/15/20243/29/202411/13/2023Quarterly$2.202.72%11/30/202312/1/202312/15/20238/22/2023Quarterly$2.201.85%9/14/20239/15/20239/29/20235/23/2023Quarterly$2.151.55%6/14/20236/15/20236/30/20232/27/2023Quarterly$2.151.51%3/14/20233/15/20233/31/2023NASDAQ traded stock with a BIG short position. (Ad)Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!See how this NASDAQ Bio-tech is offering viable solutions11/14/2022Quarterly$2.151.4%11/30/202212/1/202212/15/20228/22/2022Quarterly$2.151.4%9/14/20229/15/20229/30/20225/24/2022Quarterly$1.951.24%6/14/20226/15/20226/30/20222/25/2022Quarterly$1.951.09%3/14/20223/15/20223/31/202211/12/2021Quarterly$1.951%11/30/202112/1/202112/15/20218/30/2021Quarterly$1.951.12%9/14/20219/15/20219/30/20215/24/2021quarterly$1.751.2%6/14/20216/15/20216/30/20212/27/2021Quarterly$1.751.09%3/12/20213/15/20213/31/202111/13/2020Quarterly$1.751.14%11/30/202012/1/202012/15/20208/20/2020Quarterly$1.751.06%9/14/20209/15/20209/30/20205/22/2020quarterly$1.551%6/12/20206/15/20206/30/20202/26/2020Quarterly$1.550.99%3/13/20203/16/20203/31/202011/12/2019Quarterly$1.550.84%11/29/201912/2/201912/16/20198/19/2019Quarterly$1.550.79%9/13/20199/16/20199/30/20195/22/2019quarterly$1.350.6%6/13/20196/14/20196/28/20192/27/2019quarterly$1.350.67%3/14/20193/15/20193/29/201911/12/2018quarterly$1.350.77%11/30/201812/3/201812/17/20188/14/2018quarterly$1.350.83%9/13/20189/14/20189/28/20185/22/2018quarterly$1.200.8%6/14/20186/15/20186/29/20182/28/2018quarterly$1.200.82%3/14/20183/15/20183/30/201811/9/2017quarterly$1.200.74%11/30/201712/1/201712/15/20178/15/2017quarterly$1.200.77%9/14/20179/15/20179/29/20175/24/2017quarterly$1.050.78%6/13/20176/15/20176/30/20172/24/2017quarterly$1.050.86%3/13/20173/15/20173/31/201711/11/2016quarterly$1.050.93%11/29/201612/1/201612/15/20168/10/2016quarterly$1.050.94%9/13/20169/15/20169/30/20165/25/2016quarterly$0.900.9%6/13/20166/15/20166/30/20162/24/2016quarterly$0.900.95%3/11/20163/15/20163/31/201611/16/2015quarterly$0.900.92%11/27/201512/1/201512/15/20158/5/2015quarterly$0.900.9%9/11/20159/15/20159/30/20155/22/2015quarterly$0.750.79%6/11/20156/15/20156/30/20153/4/2015quarterly$0.750.93%3/13/20153/17/20153/31/201511/14/2014quarterly$0.750.92%11/26/201412/1/201412/15/20149/3/2014quarterly$0.750.93%9/11/20149/15/20149/30/2014625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here5/22/2014quarterly$0.640.81%6/12/20146/16/20146/30/20143/3/2014quarterly$0.640.83%3/13/20143/17/20143/31/201411/7/2013quarterly$0.640.95%11/27/201312/2/201312/16/20138/14/2013quarterly$0.641.03%9/11/20139/13/20139/30/2013(Data available from 1/1/2013 forward) Atrion Dividend - Frequently Asked Questions What is Atrion's dividend yield? The current dividend yield for Atrion is 1.91%. Learn more on ATRI's dividend yield history. How much is Atrion's annual dividend? The annual dividend for ATRI shares is $8.80. Learn more on ATRI's annual dividend history. How often does Atrion pay dividends? Atrion pays quarterly dividends to shareholders. When was Atrion's most recent dividend payment? Atrion's most recent quarterly dividend payment of $2.20 per share was made to shareholders on Friday, June 28, 2024. When was Atrion's most recent ex-dividend date? Atrion's most recent ex-dividend date was Friday, June 14, 2024. Is Atrion's dividend growing? Over the past three years, the company's dividend has grown by an average of 9.65% per year. What track record does Atrion have of raising its dividend? Atrion has increased its dividend for the past 21 consecutive years. When did Atrion last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.05 on Tuesday, August 22, 2023. What is Atrion's dividend payout ratio? The dividend payout ratio for ATRI is: 82.71% based on the trailing year of earnings 44.72% based on cash flow Is Atrion a good dividend stock? Atrion's dividend yield of 1.91% is lower than the average Medical company that issues a dividend. The company's 21 consecutive years of dividend growth indicate that the company has a strong committment to maintain and grow its dividend. Atrion's dividend payout ratio of 82.71% may not be sustainable. More Dividend Resources from MarketBeat Related Companies Utah Medical Products Dividend West Pharmaceutical Services Dividend Cooper Companies Dividend DENTSPLY SIRONA Dividend LeMaitre Vascular Dividend Embecta Dividend Iradimed Dividend Dividend Tools: Dividend Stocks Overview Dividend Investing Guide Dividend Newsletter Dividend Screener Dividend Capture Stocks Dividend Calculator Dividend Payout Ratio Calculator Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Dividend Announcements Dividend Increases Dividend Cuts Special Dividends Stock Lists: Dividend Stocks Overview Dividend Investing Guide Dividend Newsletter Dividend Screener Dividend Capture Stocks Dividend Calculator Dividend Payout Ratio Calculator Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Dividend Announcements Dividend Increases Dividend Cuts Special Dividends Latest Articles: 3 Best Dividend Stocks to Buy as Interest Rates FallIntuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy3 High-Yield Dividend Stocks for Income Now and Growth LaterDividend King ABM Industries is on Track for New HighsWhy Altria Stock is Still a Good Dividend PlayGet Paid While You Wait - OneMain's Juicy DividendsAlphabet Changes the Narrative with Its First-Ever Dividend3 High Dividend Stocks to Replace Lower Savings Yields Ahead3 Small Dividend Paying Banks Insiders are Buying More Dividend News This page (NASDAQ:ATRI) was last updated on 11/6/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredNASDAQ small cap that could be gearing up for a massive short squeeze.A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!Huge Alerts | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atrion Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atrion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
